Login / Signup

A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia.

Shilpa PaulNitin JainAlessandra FerrajoliSusan O'BrienJan A BurgerMichael KeatingWilliam G Wierda
Published in: British journal of haematology (2018)
Keyphrases
  • chronic lymphocytic leukemia
  • open label
  • placebo controlled